Bioscience Animal Health Valuation
Is BIS-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BIS-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BIS-F (THB6) is trading above our estimate of fair value (THB3.21)
Significantly Below Fair Value: BIS-F is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BIS-F?
Other financial metrics that can be useful for relative valuation.
What is BIS-F's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿1.16b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.5x |
Enterprise Value/EBITDA | 12.6x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does BIS-F's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 29.5x | ||
SMD SaintMed | 17.1x | n/a | ฿1.0b |
WINMED Winnergy Medical | 30.2x | n/a | ฿832.0m |
EFORL E for L Aim | 60.5x | n/a | ฿719.7m |
BIZ Business Alignment | 10x | n/a | ฿2.0b |
BIS-F Bioscience Animal Health | 20.1x | n/a | ฿1.2b |
Price-To-Earnings vs Peers: BIS-F is good value based on its Price-To-Earnings Ratio (20.1x) compared to the peer average (29.5x).
Price to Earnings Ratio vs Industry
How does BIS-F's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: BIS-F is good value based on its Price-To-Earnings Ratio (20.1x) compared to the TH Healthcare industry average (23.5x).
Price to Earnings Ratio vs Fair Ratio
What is BIS-F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 20.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BIS-F's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.